Clinical trial
BElimumab corticoSteroids Sparing Treatment in Systemic Lupus
NCT05624437 is registered in ClinicalTrials.gov with Centre Hospitalier de Niort as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BElimumab corticoSteroids Sparing Treatment in Systemic Lupus
- Lead sponsor
- Centre Hospitalier de Niort
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 19, 2021
- Completion date
- August 31, 2022
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sle (systemic lupus)